<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27556322</article-id><article-id pub-id-type="pmc">5062726</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160033</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Profile of Heart Donors from the Human Valve Bank of the Santa Casa
de Miseric&#x000f3;rdia de Curitiba</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ferreira</surname><given-names>Renata Maria</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>da Costa</surname><given-names>Marise Teresinha Brenner Affonso</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Canciglieri Junior</surname><given-names>Osiris</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sant'Anna</surname><given-names>&#x000c2;ngelo M&#x000e1;rcio Oliveira</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Human Heart Valve Bank of the Santa Casa
Miseric&#x000f3;rdia, Curitiba, PR, Brazil</aff><aff id="aff2"><label>2</label>Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do
Paran&#x000e1; (PUCPR), Curitiba, PR, Brazil</aff><aff id="aff3"><label>3</label>Universidade Federal da Bahia (UFBA), Salvador, BA,
Brazil</aff><author-notes><corresp id="c1">Correspondence Address: &#x000c2;ngelo M&#x000e1;rcio Oliveira
Sant'Anna, Rua Imaculada Concei&#x000e7;&#x000e3;o 1155, Curitiba, PR, Brazil -
Zip code: 80215-901. E-mail: <email>angelo.santanna@ufba.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2016</year></pub-date><volume>31</volume><issue>2</issue><fpage>191</fpage><lpage>197</lpage><history><date date-type="received"><day>11</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Human heart valves are used as replacement valves and have satisfactory
functional results compared with conventional prostheses.</p></sec><sec><title>Objective</title><p>Characterize the profile of effective heart donors from the human valve bank
of the santa casa de miseric&#x000f3;rdia de curitiba and analyze the
association between the profile variables.</p></sec><sec><title>Methods</title><p>It consists of a retrospective and quantitative study of electronic medical
records from heart donors for heart valves. every heart donation made to the
bank between january 2004 and december 2014 was studied.</p></sec><sec><title>Results</title><p>2,149 donations were analyzed, from donors aged 0 to 71 years old, with an
average of 34.9 &#x000b1; 15.03 years old. most donors were male 65.7%
(n=1,411) and 34.3% (n=738) were female. among the most frequent causes of
the donors' death are trauma at 53% (n=1,139) and cerebral vascular accident
at 34.2% (n=735). there was significant statistical association between the
analyzed variables.</p></sec><sec><title>Conclusion</title><p>There has been an improvement in brazil's donation rate, being essential that
the tissue banks work together with the state and federal district centers
for notification, procurement and distribution of organs in order to
increase the number of donors.</p></sec></abstract><kwd-group><kwd>Heart Valves</kwd><kwd>Tissue Banks</kwd><kwd>Directed Tissue Donation</kwd><kwd>Statistical Analysis</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">BD</td><td rowspan="1" colspan="1">= Brain death</td></tr><tr><td rowspan="1" colspan="1">BVCH</td><td rowspan="1" colspan="1">= Human Valve Bank</td></tr><tr><td rowspan="1" colspan="1">CNCDO</td><td rowspan="1" colspan="1">= Centers for Notification, Procurement and Distribution of Organs</td></tr><tr><td rowspan="1" colspan="1">CPA</td><td rowspan="1" colspan="1">= Cardiopulmonary arrest</td></tr><tr><td rowspan="1" colspan="1">CRA</td><td rowspan="1" colspan="1">= Cardiorespiratory arrest</td></tr><tr><td rowspan="1" colspan="1">CVA</td><td rowspan="1" colspan="1">= Cerebrovascular accident</td></tr><tr><td rowspan="1" colspan="1">SNT</td><td rowspan="1" colspan="1">= National Transplant System</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The progress of science and biotechnology has already revealed significant results,
such as the possibility of new alternatives for human tissue transplantation,
providing quality of life for victims of trauma and other degenerative diseases.
Human tissue used for therapeutic purposes, such as cardiovascular tissue, skin,
bone, cartilage, tendons, and corneas, are available from institutions known as
Tissue Banks. Those institutions have physical facilities, equipment, human
resources and techniques that enable the capture, processing, preservation, storage
and distribution of human tissue from living donors or cadavers for allogeneic
transplants<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Tissue Banks are responsible for ensuring tissue
quality, receptor safety and maintenance of a satisfactory level for the transplant
surgeons<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>Among cardiovascular tissue, human heart valves have been used as a replacement valve
since 1962. When compared with conventional prostheses, valve grafts show
satisfactory functional results, namely: physiological hemodynamic performance with
central and laminar blood flow; almost zero incidence of thromboembolism, avoiding
the use of anticoagulants; and high resistance to infections. Those specifications
result in better quality of life for patients postoperatively, and, in some series,
higher long-term survival<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>In Brazil, cardiovascular grafts are processed and made available by the Human Valve
Bank of the Hospital de Caridade da Irmandade da Santa Casa de Miseric&#x000f3;rdia
de Curitiba (BVCH). BVCH is a pioneer in the country and the only one in activity so
far. It was founded in 1996 with the purpose of providing cardiovascular tissue for
heart surgeries throughout the Brazilian territory. The bank initiative started due
to the high prevalence of valvular replacements in a low socioeconomic population
without access to adequate anticoagulant therapy<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. In view of the importance of the BVCH work,
this sudy aimed to characterize the effective donor profiles from the BVCH in the
period between January 2004 and December 2014.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This is a retrospective study of electronic records of effective heart donors for
valves, from January 2004 to December 2014, whose organs were received by BVCH. The
chosen interval is justified due to a previous study<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> which examined the
activities of the BVCH eight initial years.</p><p>Heart retrieval for valves is held in most Brazilian states by teams registered in
the Centers for Notification, Procurement and Distribution of Organs (CNCDO) and
authorized by the National Transplant System (SNT). The donation process begins with
the identification of the potential donor and family interview to offer them all
necessary information and support regarding the decision to donate. All stages of
the donation process are carried out respecting the ethical and legal principles of
Law No. 9,434, of February 4, 1997<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>, which provides for the retrieval of organ and body
tissue for transplantation and treatment. The law supports the CNCDO for organ
retrieval without previous authorization from the hospital's ethics committee. It
must be noted that, currently, organ retrieval in Brazil is carried out exclusively
in hospital environments.</p><p>The family interview is conducted by the organ and tissue transplant services present
at the hospital, in accordance with the CNCDO guidelines for organ retrieval or
removal, and the BVCH does not take part in this stage of the process. In the past
decade, obtaining permission from the family for organ and tissue retrieval was more
difficult<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>,
but recently this scenario has changed and the number of family permissions for
donations has increased<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Nevertheless, the number of donations in Brazil is much
lower compared to countries in Asia and Europe<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Potential donors for heart valves are those in brain death (in circumstances in which
the heart cannot be used for transplantation), in cardiopulmonary arrest (CPA), and
heart transplant recipients. Hearts from transplant receivers with absence of
valvulopathy are also accepted, depending on the clinical and quality inspection of
the organ during the processing of tissue.</p><p>The organs must be transported following the specific protocol established by the
BVCH, based on the Federal Decree 2600 of October 21, 2009<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>, preferably by air. The
packaging used in the transport must be triple, sterile and waterproof, closed one
by one. In the primary package, a transport solution (0.9% sodium chloride) is added
in sufficient quantity to maintain the organ totally immersed, at temperature
between 2&#x000b0;C and 8&#x000b0;C. The plastic packages containing the organ are accommodated in a
rigid and airtight container, which is then placed in an isothermal box containing
ordinary ice.</p><p>The information generated during the whole process, from the selection and screening
of the donor to the final disposal of the cardiovascular tissue, is stored in
physical and electronic means. The information available on the charts consists of
sex, race, age, cause of the donor's death, city and state where the organ was
retrieved.</p><p>Statistical analysis was performed using software SPSS 20 in order to characterize
the profiles of heart donors for valves in the period from January 2004 to December
2014. The variables were described as frequencies and analyzed using Chi-square
test, with statistical significance level of 5% (<italic>P</italic>&#x0003c;0.05).</p></sec><sec sec-type="results"><title>RESULTS</title><p>The BVCH received 2,149 donated hearts with an average &#x000b1; standard deviaton of
195.36&#x000b1;34.65 hearts/year. It was observed that there has been a growth in the
number of donations, except for a decline last year, as shown in <xref ref-type="fig" rid="f1">Figure 1</xref>. The organs received were retrieved in
20 Brazilian States. However, the analysis of the frequency of retrieval by State
showed a great discrepancy between them, as it can be seen in <xref ref-type="fig" rid="f2">Figure 2</xref>.</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Distribution of retrieved hearts between 2004 and 2014.</p></caption><graphic xlink:href="rbccv-31-02-0191-g01"/></fig>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Distribution of retrieved hearts by State.</p></caption><graphic xlink:href="rbccv-31-02-0191-g02"/></fig></p><p>Concerning age, the youngest donor was less than 1 year old and the oldest was 71
years old, with an average age of 34.9&#x000b1;15.03 years. The age group of 0 to 15
years old represented a lower proportion of donors at 9.3% (n=199), the group of 16
to 35 years old represented 39.2% (n=841), a total of 33.2% (n=713) comprised the
group of 36 to 50 years old, donors aged 51 or more represented 18.3% (n=393), and
those whose age was not reported corresponded to 0.1% (n=3) of the total number of
donors (<xref ref-type="table" rid="t1">Table 1</xref>). There was predominance of
male donors in all age groups, 65.7% (n=1,410) <italic>versus</italic> 34.3% (n=738)
of female donors. <xref ref-type="fig" rid="f3">Figure 3</xref> illustrates the
distribution of age by gender.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Distribution of heart donors by age.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th rowspan="3" align="center" colspan="1">Age</th><th colspan="4" align="center" rowspan="1">Gender</th><th colspan="2" rowspan="2" align="center">Total</th></tr><tr style="border-right:hidden;border-left:hidden"><th colspan="2" align="center" rowspan="1">Male</th><th colspan="2" align="center" rowspan="1">Female</th></tr><tr style="border-right:hidden;border-left:hidden"><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">0-15 years</td><td align="center" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">6.2%</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">3.1%</td><td align="center" rowspan="1" colspan="1">199</td><td align="center" rowspan="1" colspan="1">9.3%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">16-35 years</td><td align="center" rowspan="1" colspan="1">657</td><td align="center" rowspan="1" colspan="1">30.6%</td><td align="center" rowspan="1" colspan="1">184</td><td align="center" rowspan="1" colspan="1">8.6%</td><td align="center" rowspan="1" colspan="1">841</td><td align="center" rowspan="1" colspan="1">39.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">36-50 years</td><td align="center" rowspan="1" colspan="1">401</td><td align="center" rowspan="1" colspan="1">18.7%</td><td align="center" rowspan="1" colspan="1">312</td><td align="center" rowspan="1" colspan="1">14.5%</td><td align="center" rowspan="1" colspan="1">713</td><td align="center" rowspan="1" colspan="1">33.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x0003e;51 years</td><td align="center" rowspan="1" colspan="1">219</td><td align="center" rowspan="1" colspan="1">10.2%</td><td align="center" rowspan="1" colspan="1">174</td><td align="center" rowspan="1" colspan="1">8.1%</td><td align="center" rowspan="1" colspan="1">393</td><td align="center" rowspan="1" colspan="1">18.3%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">1410</td><td align="center" rowspan="1" colspan="1">65.7%</td><td align="center" rowspan="1" colspan="1">736</td><td align="center" rowspan="1" colspan="1">34.3%</td><td align="center" rowspan="1" colspan="1">2146</td><td align="center" rowspan="1" colspan="1">100.0%</td></tr></tbody></table></table-wrap><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Distribution of heart donors by age and gender.</p></caption><graphic xlink:href="rbccv-31-02-0191-g03"/></fig></p><p>The data analyzed showed that among the donors' cause of death, trauma was the most
frequent at 53% (n=1,139), followed by cerebrovascular accident (CVA) with 34.2%
(n=735), adverse factors to cardiology at 7.3% (n=167), cardiovascular diseases with
1.1% (n=24), and unreported causes at 0.7% (n=14). In addition, live donors (heart
transplant receivers) accounted for 3.3% (n=70) of the total donations (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><p><fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Distribution of donors according to causes of death.</p></caption><graphic xlink:href="rbccv-31-02-0191-g04"/></fig></p><p>The age and cause of death variables were associated with gender and it was noticed
the prevalence of male donors of 46.6% (n=657) in the group aged 16 to 35 years old
and 42.4% (n=312) female donors in the group of 36-50 years old
(<italic>P</italic>&#x0003c;0.001). Besides, it was observed that trauma represented more
than half of the causes of death among male donors, with 68% (n=959), and CVA was
responsible for with 59.8% (n=441) of deaths among female donors
(<italic>P</italic>&#x0003c;0.001), as shown in <xref ref-type="table" rid="t2">Table
2</xref>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Association analysis for age, causes of death and gender.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="30%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="30%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th rowspan="2" align="left" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1">Gender</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">Male (n=1.410)</th><th align="left" rowspan="1" colspan="1">Female (n=736)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;0-15 years</td><td align="center" rowspan="1" colspan="1">133 (9.4%)</td><td align="center" rowspan="1" colspan="1">66 (9.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;16-35 years</td><td align="center" rowspan="1" colspan="1">657 (46.6%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">184 (25.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;36-50 years</td><td align="center" rowspan="1" colspan="1">401 (28.4%)</td><td align="center" rowspan="1" colspan="1">312 (42.4%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003e; 50 years</td><td align="center" rowspan="1" colspan="1">219 (15.5%)</td><td align="center" rowspan="1" colspan="1">174 (23.4%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Causes of death</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Trauma</td><td align="center" rowspan="1" colspan="1">959 (68.0%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">180 (24.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">294 (20.8%)</td><td align="center" rowspan="1" colspan="1">441 (59.8%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Adverse factors</td><td align="center" rowspan="1" colspan="1">84 (6.0%)</td><td align="center" rowspan="1" colspan="1">83 (11.2%)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cardiovascular diseases</td><td align="center" rowspan="1" colspan="1">13 (0.9%)</td><td align="center" rowspan="1" colspan="1">11 (1.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Transplant receivers</td><td align="center" rowspan="1" colspan="1">50 (3.6%)</td><td align="center" rowspan="1" colspan="1">17 (2.6%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Not informed</td><td align="center" rowspan="1" colspan="1">10 (0.7%)</td><td align="center" rowspan="1" colspan="1">4 (0.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Significant association based on the adjusted residual.</p></fn></table-wrap-foot></table-wrap><p>Causes of death were analyzed by age group and it was observed that trauma is
significantly associated with donors between 16-35 years old, 81.2% (n=683), CVA was
associated with donors in the 36-50 and &#x0003e;50 years old age groups, cardiovascular
diseases and transplant receivers were associated with donors &#x0003e;50 years old
(<italic>P</italic>&#x0003c;0.001), as stated in <xref ref-type="table" rid="t3">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Association analysis for age and causes of death.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th rowspan="2" align="left" colspan="1">&#x000a0;</th><th colspan="4" align="center" rowspan="1">Age</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">0 - 15 (n=199)</th><th align="left" rowspan="1" colspan="1">16 - 35 (n=841)</th><th align="left" rowspan="1" colspan="1">36 - 50 (n=713)</th><th align="left" rowspan="1" colspan="1">&#x0003e; 50 (n=393)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Causes of death</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Trauma</td><td align="center" rowspan="1" colspan="1">114 (57.3%)</td><td align="center" rowspan="1" colspan="1">683 (81.2%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">274 (38.4%)</td><td align="center" rowspan="1" colspan="1">68 (17.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">32 (16.1%)</td><td align="center" rowspan="1" colspan="1">98 (11.7%)</td><td align="center" rowspan="1" colspan="1">348 (48.8%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">257 (65.4%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Adverse factors</td><td align="center" rowspan="1" colspan="1">49 (24.6%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">45 (5.4%)</td><td align="center" rowspan="1" colspan="1">47 (6.6%)</td><td align="center" rowspan="1" colspan="1">26 (6.6%)</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cardiovascular diseases</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">4 (0.5%)</td><td align="center" rowspan="1" colspan="1">9 (1.3%)</td><td align="center" rowspan="1" colspan="1">11 (2.8%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Transplant receivers</td><td align="center" rowspan="1" colspan="1">3 (1.5%)</td><td align="center" rowspan="1" colspan="1">9 (1.1%)</td><td align="center" rowspan="1" colspan="1">31 (4.3%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">26 (6.6%)<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Not informed</td><td align="center" rowspan="1" colspan="1">1 (0.5%)</td><td align="center" rowspan="1" colspan="1">2 (0.2%)</td><td align="center" rowspan="1" colspan="1">4 (0.6%)</td><td align="center" rowspan="1" colspan="1">5 (1.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p>Significant association based on the adjusted residual.</p></fn></table-wrap-foot></table-wrap><p>Regarding race, there was a preponderance of donors declared as white, 62.56%
(n=1,334) of the total, while 22.60% (n=486) declared themselves as
<italic>pardo</italic> and 9.12% (n=196) as black. An additional 5.72% (n=122)
did not provide information relating to race in their records. Causes of death were
also analyzed according to race and it was observed that trauma is significantly
associated with donors declared as <italic>pardo</italic>, 57.6% (n=280), CVA was
associated with black donors and transplant receivers with donors declared white
(<italic>P</italic>&#x0003c;0.001), as shown in <xref ref-type="table" rid="t4">Table
4</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Association analysis for race and causes of death.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="30%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th rowspan="2" align="left" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1"> Race</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">White (n=1.345)</th><th align="left" rowspan="1" colspan="1">Black (n=196)</th><th align="left" rowspan="1" colspan="1"><italic>Pardo</italic> (n=486)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Causes of death</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Trauma</td><td align="center" rowspan="1" colspan="1">713 (53.0%)</td><td align="center" rowspan="1" colspan="1">90 (45.9%)</td><td align="center" rowspan="1" colspan="1">280 (57.6%)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">466 (34.6%)</td><td align="center" rowspan="1" colspan="1">88 (44.9%)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">152 (31.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Adverse factors</td><td align="center" rowspan="1" colspan="1">102 (7.6%)</td><td align="center" rowspan="1" colspan="1">12 (6.1%)</td><td align="center" rowspan="1" colspan="1">36 (7.4%)</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cardiovascular diseases</td><td align="center" rowspan="1" colspan="1">16 (1.2%)</td><td align="center" rowspan="1" colspan="1">1 (0.5%)</td><td align="center" rowspan="1" colspan="1">5 (1.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Transplant receivers</td><td align="center" rowspan="1" colspan="1">42 (3.1%)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">3 (1.5%)</td><td align="center" rowspan="1" colspan="1">11 (2.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Not informed</td><td align="center" rowspan="1" colspan="1">6 (0.4%)</td><td align="center" rowspan="1" colspan="1">2 (1.0%)</td><td align="center" rowspan="1" colspan="1">2 (0.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>*</label><p>Significant association based on the adjusted residual.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Brazil stands out in the area of transplantation by owning one of the largest public
programmes of organ and tissue transplantation in the world, working through a
systematic and official protocol; however, a growing imbalance between supply and
demand remains.</p><p>The deficiency of organ donation is a universal obstacle and the donor is the most
important factor in the provision of tissue for transplantation<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The shortage of organ
donors is not primarily the result of a lack of donors, but rather the difficulty of
identifying them, getting the family's consent and retrieving the organ and/or
tissue in a timely manner. In this context, intra-hospital transplant committees are
essential in identifying the potential donor and promptly notifying the State
Transplant Centers<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>The evolution of patients with brain death (BD) to cardiorespiratory arrest (CRA) was
one of the main causes of non-completion of the donation of solid organs for
transplantation in 2012, reaching 52% in some Brazilian regions<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. It is worth mentioning
that for donation of a solid organ for transplantation the potential donor should
necessarily have only the diagnosis of BD. However, for human tissue donations,
donors that had evolved into CRA are accepted. The number of corneal tissue
donations has increased from donors who were given the diagnosis of BD and had
evolved to CRA<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>. In the analysis of the
profile of BVCH donors, it was observed that there is less family refusal in
situations in which the potential donor was in CRA. It is assumed that most of the
lay population believes that death occurs only with heartbeat cessation.</p><p>In a previous study conducted about survival<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>, between 1996 and 2004, BVCH received 1,041
hearts, with an average of 115 hearts/year. The progressive growth in the number of
donations occurred because of the establishment of the National Transplant System in
1997. In the period of this study (2004 to 2014), BVCH received 2,149 hearts, with
an average of 195 hearts/year. In the past seven years, Brazil presented a gradual
and sustained growth in the number of organ and tissue donations, though below
target<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.
Considering the number of organ retrievals by State, a disparity among them was
noticed, which suggests a reflection not only of the teams' willingness and
commitment, but also the activities of the States Transplant Centers.</p><p>It is essential that there be an interaction between the Organ and Tissue Banks and
the State Centers of Organ Donation, promoting greater organ and tissue
donation<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. It is important that these Centers collaborate more
effectively with the organ retrieval centers and health authorities, training the
professionals involved in the process of screening and selecting donors and
retrieving tissue. Furthermore, it is necessary to support studies in the
development and implementation of programmes to raise awareness of the population
about organ and tissue donation.</p><p>The results come closer to national data concerning the profile of organ and tissue
donors, since each Tissue Bank has technical and legal standards to follow for
selection and collection. There are also minimum and maximum ages of donors for each
type of tissue; for example, the age of a heart donor for heart valves is similar to
those presented, which points to a higher prevalence of 18-64 year
olds<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Concerning gender, there was a predominance of males, representing 65.7% of donors
(n=1,411), and 60% of the effective organ and tissue donors in Brazil are male. The
same pattern is found in Spain, world reference in organ and tissue retrieval, where
60.7% of donors are male<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Trauma contributed highly to heart donation for heart valves. The results were
similar to the literature, with a great prevalence of traumatic causes, reflecting
the violence in today's society, and CVA as main cause of death<sup>[<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Comparing the causes of death with gender and age
of the donors, it was noted that trauma was the major cause of death of men aged
between 16 and 35 years old, while CVA prevailed among women in the age group of 15
to 36 years old<sup>[<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This study is presented as a pioneer for the country's transplant scenario,
describing the profile of heart valve donors. The information offered can contribute
to the evaluation and monitoring of the operation as well as the implementation and
efficiency of the actions proposed by the transplant policy in national, state and
local levels.</p><p>The lack of training of health professionals and of population knowledge about the
organ donation process directly impact the number of donors and, consequently, the
number of transplants. Thus, it is essential that the Tissue Banks work together
with the CNCDs in developing professional training and permanent educational
programs for awareness, education and encouragement of the population since the
family's refusal is one of the main obstacles for effective organ and tissue
donation.</p><p>As future work, it is recommended studies that approach issues such as tissue
disposal in the pre and post-processing stages, qualified and released tissue for
transplant, and tissue recipients'profile.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">RMF</td><td rowspan="1" colspan="1">Conception and study design; execution of operations and/or trials;
analysis and/or data interpretation; final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">MTBAC</td><td rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">OCJ</td><td rowspan="1" colspan="1">Final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">AMOSA</td><td rowspan="1" colspan="1">Analysis and/or data interpretation; statistical analysis;
manuscript writing or critical review of its content; final
manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Hospital de Caridade da Irmandade da Santa Casa de
Miseric&#x000f3;rdia de Curitiba, Curitiba, PR, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Brasil</collab><collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab></person-group><year>2009</year><source>Portaria n.&#x000ba; 2.600/GM, de 21 de outubro de 2009. Aprova o
Regulamento T&#x000e9;cnico do Sistema Nacional de Transplantes</source><publisher-loc>DF</publisher-loc><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://bvsms.saude.gov.br/bvs/saudelegis/gm/2009/prt2600_21_10_2009.html">http://bvsms.saude.gov.br/bvs/saudelegis/gm/2009/prt2600_21_10_2009.html</ext-link></comment><date-in-citation content-type="access-date">21 Apr 2015</date-in-citation></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiozer</surname><given-names>W</given-names></name></person-group><article-title>Banco de pele no Brasil</article-title><source>Rev Bras Queimaduras</source><year>2012</year><volume>11</volume><issue>2</issue><fpage>53</fpage><lpage>55</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>F</given-names></name><name><surname>Dohmen</surname><given-names>P</given-names></name><name><surname>Vieira</surname><given-names>E</given-names></name><name><surname>Lopes</surname><given-names>SV</given-names></name><name><surname>Colatusso</surname><given-names>C</given-names></name><name><surname>Pereira</surname><given-names>EWL</given-names></name><etal/></person-group><article-title>Opera&#x000e7;&#x000e3;o de Ross com homoenxertos valvares
decelularizados: resultados de m&#x000e9;dio prazo</article-title><source>Rev Bras Cir Cardiovasc</source><year>2007</year><volume>22</volume><issue>4</issue><fpage>454</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">18488113</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>MTBA</given-names></name><name><surname>Costa</surname><given-names>FDA</given-names></name><name><surname>Nazareno</surname><given-names>LCF</given-names></name><name><surname>Domchoski</surname><given-names>J</given-names></name><name><surname>Peruzzo</surname><given-names>AM</given-names></name><name><surname>Colatusso</surname><given-names>C</given-names></name><etal/></person-group><article-title>An&#x000e1;lise das atividades dos oito anos iniciais do Banco de
Valvas Card&#x000ed;acas Humanas do Hospital de Caridade da Irmandade da
Santa Casa de Miseric&#x000f3;rdia de Curitiba</article-title><source>Rev Bras Cir Cardiovasc</source><year>2005</year><volume>20</volume><issue>4</issue><fpage>8</fpage><lpage>17</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="legal-doc"><person-group person-group-type="author"><collab>Brasil</collab><collab>Presid&#x000ea;ncia da Rep&#x000fa;blica</collab></person-group><year>1997</year><source>Lei n.&#x000ba; 9.434, de 4 de fevereiro de 1997. Bras&#x000ed;lia.
Disp&#x000f5;e sobre a remo&#x000e7;&#x000e3;o de &#x000f3;rg&#x000e3;o, tecidos
e partes do corpo humano para fins de transplante</source><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.planalto.gov.br/ccivil_03/leis/L9434.htm">http://www.planalto.gov.br/ccivil_03/leis/L9434.htm</ext-link></comment><date-in-citation content-type="access-date">15 Feb 2016</date-in-citation></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>First</surname><given-names>MR</given-names></name></person-group><article-title>Transplantation in the nineties</article-title><source>Transplantation</source><year>1992</year><volume>53</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">1370734</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname><given-names>WL</given-names></name><name><surname>Seck</surname><given-names>T</given-names></name><name><surname>Tay</surname><given-names>CP</given-names></name><name><surname>Chua</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Homograft banking in Singapore: two years of cardiovascular
tissue banking in Southeast Asia</article-title><source>Cell Tissue Bank</source><year>2013</year><volume>14</volume><issue>2</issue><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">22538986</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jashari</surname><given-names>R</given-names></name><name><surname>Van Hoeck</surname><given-names>B</given-names></name><name><surname>Tabaku</surname><given-names>M</given-names></name><name><surname>Vanderkelen</surname><given-names>A</given-names></name></person-group><article-title>Banking of the human heart valves and the arteries at the
European homograft bank (EHB): overview of a 14-year activity in this
International Association in Brussels</article-title><source>Cell Tissue Bank</source><year>2004</year><volume>5</volume><issue>4</issue><fpage>239</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">15591827</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiratori</surname><given-names>CN</given-names></name><name><surname>Hirai</surname><given-names>FE</given-names></name><name><surname>Sato</surname><given-names>EH</given-names></name></person-group><article-title>Caracter&#x000ed;sticas dos doadores de c&#x000f3;rneas do Banco de
Olhos de Cascavel: impacto do exame anti-HBc para hepatite B</article-title><source>Arq Bras Oftalmol</source><year>2011</year><volume>74</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21670901</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>TB</given-names></name><name><surname>Chagas</surname><given-names>MIO</given-names></name><name><surname>Brito</surname><given-names>MCC</given-names></name><name><surname>Sales</surname><given-names>DS</given-names></name><name><surname>Silva</surname><given-names>RCC</given-names></name><name><surname>Souza</surname><given-names>AMA</given-names></name></person-group><article-title>Perfil de potenciais doadores de &#x000f3;rg&#x000e3;os em hospital
de refer&#x000ea;ncia</article-title><source>Rev Rene</source><year>2013</year><volume>14</volume><issue>4</issue><fpage>713</fpage><lpage>719</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paz</surname><given-names>ACAC</given-names></name></person-group><article-title>Caracteriza&#x000e7;&#x000e3;o dos doadores de &#x000f3;rg&#x000e3;os
e tecidos para transplante do Estado do Piau&#x000ed;, de 2000 a
2009</article-title><source>Enfermagem em Foco</source><year>2001</year><volume>2</volume><issue>2</issue><fpage>1247</fpage><lpage>1247</lpage></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavagnoli</surname><given-names>CF</given-names></name><name><surname>Severino</surname><given-names>ES</given-names></name><name><surname>Vilarinho</surname><given-names>KA</given-names></name><name><surname>Silveira Filho</surname><given-names>LM</given-names></name><name><surname>Oliveira</surname><given-names>PP</given-names></name><name><surname>Petrucci</surname><given-names>O</given-names></name><etal/></person-group><article-title>Associated factors with survivals in patients undergoing
orthotopic heart transplant using retrograde blood
microcardioplegia</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>3</issue><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">23288174</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Associa&#x000e7;&#x000e3;o Brasileira de Transplante de
&#x000d3;rg&#x000e3;os</collab></person-group><source>Entendendo a doa&#x000e7;&#x000e3;o de &#x000f3;rg&#x000e3;os, 2008</source><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.abto.org.br/">http://www.abto.org.br/</ext-link></comment><date-in-citation content-type="access-date">21 Feb 2015</date-in-citation></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales Pedraza</surname><given-names>J</given-names></name><name><surname>Lobo Gajiwala</surname><given-names>A</given-names></name><name><surname>Martinez Pardo</surname><given-names>ME</given-names></name></person-group><article-title>A review of the International Atomic Energy Agency (IAEA)
international standards for tissue banks</article-title><source>Cell Tissue Bank</source><year>2012</year><volume>13</volume><issue>1</issue><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">20714807</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Associa&#x000e7;&#x000e3;o Brasileira de Transplante de
&#x000d3;rg&#x000e3;os</collab></person-group><article-title>Dimensionamento dos Transplantes no Brasil e em Cada Estado:
2007-2014</article-title><source>RBT</source><year>2009</year><volume>XX</volume><issue>4</issue><fpage>1</fpage><lpage>85</lpage><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.abto.org.br/abtov03/Upload/file/RBT/2014/rbt2014-lib.pdf">http://www.abto.org.br/abtov03/Upload/file/RBT/2014/rbt2014-lib.pdf</ext-link></comment><date-in-citation content-type="access-date">21 Feb 2015</date-in-citation></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Organizacion Nacional de Trasplates</collab></person-group><source>Memoria de Actividad</source><publisher-loc>Espanha</publisher-loc><year>2009</year><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ont.es/infesp/Memorias/Forms/AllItems.aspx">http://www.ont.es/infesp/Memorias/Forms/AllItems.aspx</ext-link></comment><date-in-citation content-type="access-date">21 Apr 2015</date-in-citation></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname><given-names>MIF</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>TOM</given-names></name><name><surname>Cavalcante</surname><given-names>MMS</given-names></name><name><surname>Chaves</surname><given-names>ES</given-names></name><name><surname>Rolim</surname><given-names>ILTP</given-names></name></person-group><article-title>Perfil de doadores efetivos de &#x000f3;rg&#x000e3;os e tecidos no
Estado do Cear&#x000e1;</article-title><source>Rev Min Enferm</source><year>2010</year><volume>14</volume><issue>3</issue><fpage>353</fpage><lpage>360</lpage></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulinari</surname><given-names>LA</given-names></name><name><surname>Navarro</surname><given-names>FB</given-names></name><name><surname>Pimentel</surname><given-names>GK</given-names></name><name><surname>Miyazaki</surname><given-names>SM</given-names></name><name><surname>Binotto</surname><given-names>CN</given-names></name><name><surname>Pelissari</surname><given-names>EC</given-names></name><etal/></person-group><article-title>The use and midium-term evaluation of decellularized allograft
cusp in the surgical treatment of the tetralogy of Fallot</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">18820782</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraes</surname><given-names>EL</given-names></name><name><surname>Silva</surname><given-names>LBB</given-names></name><name><surname>Moraes</surname><given-names>TC</given-names></name><name><surname>Paix&#x000e3;o</surname><given-names>NCS</given-names></name><name><surname>Izumi</surname><given-names>NMS</given-names></name><name><surname>Guarino</surname><given-names>AJ</given-names></name></person-group><article-title>O perfil de potenciais doadores de &#x000f3;rg&#x000e3;os e
tecidos</article-title><source>Rev Latino-Am Enfermagem</source><year>2009</year><volume>17</volume><issue>5</issue><fpage>716</fpage><lpage>720</lpage></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>FDA</given-names></name><name><surname>Fornazari</surname><given-names>DF</given-names></name><name><surname>Matsuda</surname><given-names>CN</given-names></name><name><surname>Torres</surname><given-names>RA</given-names></name><name><surname>Sardetto</surname><given-names>E</given-names></name><name><surname>Ferreira</surname><given-names>ADA</given-names></name><etal/></person-group><article-title>Ten years experience of aortic valve replacement with aortic
homograft root replacement</article-title><source>Braz J Cardiovasc Surg</source><year>2006</year><volume>21</volume><issue>2</issue><fpage>155</fpage><lpage>164</lpage></element-citation></ref></ref-list></back></article>